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Background: Knee osteoarthritis is a disease of the joint causing decreased function and pain. 
Currently, treatments range from medication to surgery, with the use of different insoles and 
footwear recommended. These methods are effective by either correcting the position of the 
knee or providing shock absorption. However, there is little understanding of the effective 
characteristics of these devices.  
Research question: This paper aims to investigate this question and provide future areas of 
research to help better define treatment guidelines. Foot orthoses are an example of non-
pharmacological conservative treatments mentioned in National Institute for Health and Care 
Excellence (NICE) guidelines to treat knee osteoarthritis (OA). These include lateral wedge 
insoles (LWI), developed with the intention of load reduction of the knee. Different footwear 
has also been shown to affect pain, biomechanical and functional outcomes in knee OA 
patients.  
Methods: To address what features of LWIs and footwear make them effective in the treatment 
of knee OA, scientific databases were used to search for papers on this topic and then selected 
to be included based on pre-defined criteria. Data were extracted and analysed from these 
studies to provide a basis for possible areas for future development of these foot orthoses, and 
research required to improve clinical treatment guidelines. Databases used were PubMed, 
Scopus and Web of Science.  
Results and Significance: Thirty-four out of 226 papers were included after application of 
inclusion and exclusion criteria.  Regarding LWIs, the characteristics showing the most 
beneficial effect on either biomechanical, functional or pain outcomes were customisation, full-
length, 5° elevation, shock absorption and arch support. For footwear, barefoot mimicking 
soles produced the most favourable biomechanics. Results also showed that insoles work in 
correcting the position of the knee, but it may or may not affect patients’ pain and function.  
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1. Introduction  
1.1. Background 
Knee Osteoarthritis (OA) is a common medical condition seen in primary care affecting 1 in 5 
adults over the age of 45 in the UK [1].  It is comprised of varying levels of functional 
limitations and associated with reduced quality of life (QOL) [2]. OA is a metabolically active 
process involving all joint tissues, i.e. bone, synovium and muscle [3]. Pathological changes 
include loss of joint space through the degradation of joint cartilage, and new bone formation 
at the joint site would cause several malfunctions (osteophytes) [4]. This breakdown and repair 
process supports the idea that OA is a repair process for synovial joints and trauma may be the 
trigger. Symptomatic OA occurs when either the repair process is blunted, or the initial trauma 
is above the repair threshold, resulting in continuing tissue damage [5]. Knee OA has multiple 
risk factors, usually divided into subgroups: genetic factors [6-9], constitutional factors [10-
12], age [13], sex [14, 15], Body Mass Index (BMI) [16-20] and biomechanical factors [21-26] 
. Heritability for OA is estimated to be around 40-60% [5]. Females, particularly post-
menopausal, tend to have a higher incidence of knee OA, and this sex difference is well 
documented amongst several studies [27-29]. It is also shown that having previous knee trauma 
increases the risk of knee OA by 3.86 times [30]. Clinically, the most common symptoms of 
knee OA are persistent knee pain, morning stiffness and reduced function; the triad of 
symptoms recommended by the European League Against Rheumatism (EULAR) for the 
diagnosis of knee OA [31]. Pain is the underlying cause of most of the disability seen in knee 
OA and is usually exacerbated by activity and relieved by rest. It is thus  a vital component for 
disease monitoring by clinicians [30]. Several scoring systems are in place to aid clinicians in 
monitoring the severity of limitations for knee OA patients [32]. The Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) is a physical function subscale widely 
used as a patient-reported measurement tool for knee OA, covering physical function, pain, 
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stiffness and other symptoms [33]. WOMAC scoring has been well validated and is widely 
used in medical practice and clinical trials [34]. Radiologically, X-Rays are the initial port of 
call as they show bony malformations that may exist within the joint. The Kellgren Lawrence 
(KL) scale is a radiographic classification scheme for OA, which is commonly used both as a 
research tool for OA studies, and as a potential aid for clinical treatment algorithms. It ranges 
from grade 0-4, with grade “0” signifying no presence of OA and grade “4” signifying severe 
OA, based on several radiological findings, i.e. the formation of osteophytes [35].  
The most common form of OA occurs at the medial compartment of the knee and is due to a 
higher transfer of load to the medial compartment during normal gait compared to the lateral 
compartment [36]. Pain and functional impairment on the medial side are caused by this 
asymmetry in loading, resulting in an adduction of the knee moment throughout the stance 
phase of gait. This often causes a valgus malalignment in patients, causing a greater shift in 
stress to the medial compartment. It is shown that a high knee adduction moment (KAM) and 
varus malalignment in load bearing are predictors for disease progression in knee OA [37, 38]. 
Therefore, reducing loading to the medial side of the knee during daily life should have  
positive, and sometime long-lasting, effects on patients with medial knee OA. This in fact is a 
strategy currently employed by several conservative treatment methods.  
According to the National Institute for Health and Care Excellence (NICE) guidelines, initial 
treatment involves the encouragement of patients to undertake -=self-management [39]. This 
ranges from undergoing weight loss and/or exercising to increase the patient’s local muscle 
strength [40]. Following this, pharmacological treatments, i.e. pain killers and anti-
inflammatory medication, are offered that usually involve symptom control [41]. The most 
severe cases of knee OA have surgical treatments offered; these range from a high tibial 
osteotomy to full joint replacements [42]. This is currently a massive financial burden on the 
National Health System (NHS) in the UK, with OA joint replacement surgeries costing £405 
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million per year [43]. NICE also mentions non-pharmacological conservative treatments in its 
guidelines. Adjunct treatments include thermotherapy [44], electrotherapy [45] and walking 
aids [46]. 
 
1.2.  Description of the intervention 
Foot orthoses are an example of non-pharmacological conservative treatments mentioned in 
NICE guidelines. These include lateral wedge insoles (LWI), which are developed with the 
intention of load reduction of the knee, in this context of the medial compartment, by creating 
a valgus effect on the knee. Shock absorbing insoles and different types of footwear have a 
cushioning effect on the knee [47]. All of these interventions are used to improve function by 
reducing the symptoms of knee OA, and possibly slow down disease progression [48].  A LWI 
laterally shifts the centre of pressure, causing a more vertical ground reaction force. This causes 




Research is currently split regarding the effectiveness of LWIs. While NICE recommend the 
possible use of LWIs, European League Against Rheumatism (EULAR) have rejected the 
recommendation based on evidence showing no clinical effects. However, since the publication 
of these recommendations in 2012, research has shown positive effects of the use of LWIs. 
Several review papers have looked at this. Thus, Roodsari et al. concluded that LWIs could 
provide changes in KAM, pain and function in Knee OA [50]. On the other hand, Cochrane’s 
review concluded that the optimal choice for an orthosis is unclear, with long term effects 
inconclusive [51]. Regarding footwear, currently EULAR and NICE recommend appropriating 
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footwear to knee OA patients. However, at present no systematic review exists looking at the 
effect of footwear on knee OA.  
Many different types of LWIs and footwear exist within clinical practice. Currently, no review 
exists looking at specific features of LWIs and footwear that make them effective (and those 
that maybe ineffective), as well as looking at those that may be superior for the treatment of 
knee OA. This systematic review aims to be the first to address this issue in the treatment of 
knee OA and moreover, provide a basis for possible areas for future development of these foot 
orthoses, and suggest further research that is required to improve clinical treatment guidelines.
  
2. Material and Methods 
2.1. Search methods for identification of studies 
The search strategy was based on the Population Intervention Comparison Outcome (PICO) 
(Table 1).  
 
Table 1: The Population Intervention Comparison Outcome (PICO) used when creating the 
search strategy 
Published research from 2000 to 2019 was searched for on PubMed, Scopus and Web of 
Science using the following keywords: 
1-    ‘Knee osteoarthritis’ (other variations of osteoarthritis used as well i.e. 
osteoarthrosis, degenerative knee disease) 
2-    ‘Foot Orthoses’ (other variations of orthoses used as well i.e. orthotic, orthosis) 
3-    Insoles 




The following combinations were used:  
1 OR 2, 1 OR 3, 1 OR 4,  
1 AND 2, 1 AND 3, 1 AND 4,  
Relevant articles where then identified and selected for evaluation. No language restrictions 
were applied. Papers were reviewed following the Preferred Reporting Items for Systematic 
Review and Meta-Analyses (PRISMA) method [52].  Titles were then screened to eliminate 
duplications and then proceeded to abstract screening. 
 
2.2. Inclusion and exclusion criteria 
All abstracts were assessed for eligibility using the inclusion criteria found in Tabel 2. Full text 
articles where then assessed against our exclusion criteria (Table 2) and discarded if any of 
those criteria were met.  
 
Table 2: Inclusion and exclusion criteria used during the screening process of papers 
 
This situation arose where the same patient population was used for several reports, in this 
instance this study used the larger group of patients, or the report with the longer follow up 
period. Figure 1 shows the summarised search process in a PRISMA flowchart. 
 
Figure 1: The flow diagram followed using the Preferred Reporting Items for Systematic 




2.3. Assessment of study quality 
Risk of bias was assessed by looking at the papers’ sampling methods, description of dropouts 
and withdrawals. Journal strength was then assessed through SCImago Journal ratings [53]. 
Only papers published in journals with ratings in Quartile 2 and above were included in journals 
that had relevance to the reviews subject area. This would include journals in subject areas 
such as musculoskeletal problems, orthopaedics, arthritis, rheumatology, gait and posture, 
physical medicine and rehabilitation etc.  
 
2.4. Data extraction 
Data extraction was conducted by extracting data on study design, methods used, sample size, 
interventions, outcome measures on KAM, pain, function and follow-up periods using a 
standardised form.  
 
2.5. Data presentation and analysis 
Extracted data were then sorted into those relating to either LWIs or shoes and were presented 
in tables. These allowed comparisons of data that enables a consensus to be reached for the 
research question.  
3. Results 
3.1. Search results 
The search strategy resulted in 226 articles from the following databases: PubMed, Scopus and 
Web of Science. Ninety-eight articles were removed due to duplications. One hundred and 
twenty-eight records’ titles and abstracts were then screened against the inclusion criteria, 
which resulted in removing 35 papers as they did not meet the requirements for study design. 
The remaining 93 articles were assessed against the exclusion criteria using the full texts, and 
59 articles were removed as they satisfied one or more exclusion criteria (the most prevalent 
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being the use of other concurrent treatment, n=22). All reasons for discarding papers along 
with numbers can be seen in Figure 1. Thirty-four studies remained and were included in this 
systematic review. 
 
3.2. Study characteristics 
The 34 studies chosen to be included in this paper had various characteristics and demographics 
(Table 3).  
 
Table 3: Study characteristics of the papers included in this systematic review 
 
The publishing year for the papers ranged from 2002 to 2018. Cohort sizes ranged from 8 to 
200, with the mean being 57 participants. Fourteen papers were randomised control trials, 18 
had a pre-post intervention study design, 1 was a cross-sectional observational study and there 
was also a single prospective case-control study. Regarding interventions used by the studies, 
22 papers looked at LWIs; 12 looking specifically at the effectiveness of LWIs compared to a 
control (either no insole or a neutral one) [40, 49, 54-63], 2 looked at the effect of insole rigidity 
[64, 65], 2 at insole customisation [66, 67], 1  at the effect of insole length [68], 2  at the effect 
of different elevations of LWIs [69, 70], 1 at the correlation between disease severity and 
LWIs’ effectiveness [71], and finally 2 papers investigated the effectiveness of arch support 
[72, 73]. Eleven papers looked at footwear’s effect on knee OA: 1 at the effect of different 
footwear of knee OA [74], 5 at barefoot mimicking shoes [75-79], 3 at variable sole height 
shoes [80-82], and 2 at variable stiffness shoes [83, 84]. The remaining 1 paper compared the 
effectiveness of shoes and insoles on knee OA [85]. Regarding outcome measures, all papers 
looked at least one of the primary outcome measures we wanted to assess. Eight papers used 
the WOMAC score to assess and monitor disease function, and 24 papers conducted some 
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biomechanical analysis, i.e. external KAM [86]. Several other outcomes were also looked at, 
namely, pain medication use, pain on Visual Analogue Scale (VAS) [87] and Knee Injury and 
Osteoarthritis Outcome Score (KOOS) [88, 89]. Finally, follow-up periods ranged from 
immediate testing to 2 years follow-up, with the mean study length being 12 weeks. 
 
3.3. Methodological quality 
Overall the methodological quality of the studies included in this paper was good (See Table 
4).  
Table 4: Journal quality for studies included in this systematic review 
 
Twenty-seven out of the 34 papers (79%) were from Q1 SCImago Journal rated papers. 
Twenty-five out of the 34 published studies (74%) were randomised for either intervention or 
order of testing condition, reducing selection bias. Twenty-one studies (62%) had no drop-outs 
by participants, and 2 did not provide any information on drop-out rates. Of the remaining 11 
papers, 2 did not provide reasons for patient withdrawal, and the rest presented valid 
explanations. The highest proportional participant withdrawal was in the study of Pham et al. 
(2004) with a 17.9% drop-out rate; reasoning ranged from participants undertaking surgery, to 
participants could not be traced during follow-up. Eighteen papers (53%) mentioned statistical 
power in the full text, of which 14 reached a statistical power of 80% or above. 
 
3.4. Lateral insoles 
Table 5 shows the results for all the papers regarding LWIs. Eleven papers were found 




Table 5: List of studies that evaluated the effect of foot orthoses on pain, functional and 
biomechanical outcomes on medial compartment knee osteoarthritis patients 
 
Baker et al. compared 5° LWIs to a neutral insole in a randomised control trial (RCT), and 
found a 13.8% point effect on the WOMAC pain subscale at 6 weeks follow-up (P=0.13) [54]. 
Similar improvements in pain were seen in Hsu et al.’s intervention study [56]. Hinman et al.’s 
intervention found a reduction of 24% in walking pain, along with a 3-month improvement in 
WOMAC pain and function subscale (P = 0.004) [68]. However, several papers found either 
no effects on pain or a similar effect on pain in both the intervention and control groups. 
Bennell et al. showed a pain reduction that was not clinically relevant for both LWIis’ and 
neutral insole groups in a large RCT [57]. Pham et al. (2004) found no statistical difference in 
disease severity or WOMAC subscales (including pain) after 2 years in another large RCT, but 
did find that the intervention group had a reduction in the number of days with NSAID intake 
(71 compared to 127) [59]. This similar reduction in severity of pain for both groups (P < 
0.001), and reduction in NSAID intake in the intervention group, was also found by Hatef et 
al. [26] (P = 0.001). Moreover, Barrios et al. found a similar reduction in WOMAC score for 
both the intervention and control groups [60]. Regarding knee mechanics, there was a 
consensus of findings that LWIs decreased unfavourable knee biomechanics. Hsu et al. found 
a reduction in KAM at baseline, along with a change in gait at 6 weeks testing without the 
insoles (p < 0.05). The change in gait showed a reduction in KAM [56]. Hinman et al. showed 
LWIs reduced peak KAM (-5.8%) and angular impulse (-6.3%) in immediate testing (P<0.001) 
[49], and this was similarly replicated by Lewinson et al. [62].  Barrios et al. showed that KAM 
increased for the control group (subjects with knee OA without LWIs) over a year, whereas 
LWIs mitigated this increase, and they remained biomechanically active over 1 year of wear 
[60]. Sawada et al. [61] showed LWIs decreased first peak KAM in a normal foot group (-10% 
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P, 0.001), but remained unchanged in an abnormal (either everted on inverted) foot group. 
Alshawabka et al. found that this reduction in KAM due to LWIs was maintained during stair 
ascent and descent along with KAII (all P<0.05) [55]. Finally, Baker et al. assesed 50 feet 
walking time and chair stand time, finding small improvements in both scores but below 
clinical relevance [54]. Hatef et al. looked at the Edinburgh Knee Function Scale (EKFS) [90], 
and found significant improvement in the LWI group (P < 0.001) [63]. 
 
3.4.1. Size/elevation 
Regarding pain, Rafiaee et al. compared 3mm vs 7mm insoles, and found that both wedge 
heights improved knee joint pain and quality of life (QOL) scores, with the 7mm insole 
(approximately 6°) having the most significant effect [70]. However, Dessery et al. found no 
difference in comfort or pain ratings between neutral, 6° and 10° insoles [72]. Biomechanically, 
Kerrigan et al. report that when compared with no insole, the 5° wedge reduced the peak KAM 
values by 6%, and the 10° wedge reduced the peaks by 8% [69]. This dose effect of LWI 
elevation was also found by Allan et al. (p < 0.001) [66], but Dessery et al. found no significant 
difference between 6° and 10 ° insoles; both having a 6% decrease in 2nd peak KAM compared 
to neutral or no LWI (p<0.001) [72]. No studies except Rafiaee et al.’s looked at quality of life 
measure, as mentioned previously [70]. 
 
3.4.2.  Insole rigidity 
Turpin et al. saw an improvement in the WOMAC pain subscale scores for shock absorbing 
insoles compared to no wedge (P<0.05) [64]. Hseih et al. found significant time × group effect 
improvements in pain (P = 0.008 for the KOOS) for soft LWIs compared to rigid LWIs [65]. 
Gait analyses for shock absorbing insoles revealed a significant reduction in the late stance 
peak KAM (P=0.03) during follow-up compared with the baseline test session [64]. 
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Functionally, shock absorbing insoles reduced the timed stair climb (P<0.05) [64], and soft 
LWIs saw improvements in stair ascent time (P = 0.003), daily living function (P = 0.003 for 
the KOOS), sports and recreation function (P = 0.012 for the KOOS), and quality of life (P = 
0.021 for KOOS) [65]. 
 
3.4.3.  Length 
Hinman et al. found full-length LWIs reduced KAM by 12-14% (P < 0.05), whereas rear foot 
wedging had no effectsf (P < 0.05) [58]. This finding was reciprocated by Allan et al., who 
showed full-length orthoses provided a greater reduction in first and second (5° forefoot/10° 
rearfoot wedging) KAM (p = 0.038) and KAM impulse compared to ¾ insoles  (p = 0.018) 
[66]. 
 
3.4.4. Arch support 
Dessery et al. found no differences in comfort or pain rating between no insoles, insoles with 
only one medial arch, and LWIs with medial arches at 6° and 10° [72]. However, Jones et al. 
found a significant reduction in pain in supported wedges (with medial arch) compared to 
typical wedges (p <0.001) (36).  There was a 6% decrease in 2nd peak KAM in LWI conditions 
compared to others (p<0.001), and a 7% significant increase in KAM during loading response 
(a phase during walking) in neutral insoles with a medial arch [72]. Jones et al. found that 
external KAM was reduced in both typical and supported LWIs versus a control shoe (−5.21% 
and −6.29% respectively) but that there was no difference between the two groups [73]. No 





Skou et al. created custom insoles for participants and found the knee pain due to the OA (as 
rated on a VAS) after 30 minutes of physical activity, which was significantly reduced after 
the intervention (P= 0.001). Similar changes were seen for quality of life measurements [67]. 
  
3.4.6. Disease severity 
Hinman et al. reported that disease severity, along with baseline functioning, the magnitude of 
immediate change in walking pain and first peak KAM, accounted for 24% of the variance 
seen in the WOMAC pain score at 3 months [58]. Shimada et al. found that LWIs significantly 
reduced the peak external KAM in KLre grades I (5.1% P=<0.043), II (6.6%, P=<0.010), III 
(3.3%, p<0.058) and IV (5.0%, P<0.086) [71]. The first acceleration peak after heel strike was 
only significantly reduced in KL grades I (P<0.024) and II (P<0.043) [71]. Functional 
outcomes were not tested in these studies. 
 
3.5. Footwear 
Table 6 shows the results for all the papers regarding footwear. Shakoor et al. compared the 
effect of common footwear on peak knee loads. and found that clogs and stability shoes resulted 
in a significantly higher peak KAM (p<0.05) compared with that of flat walking shoes, flip-
flops and barefoot walking [74].  
 
Table 6: Studies that evaluated the effect of footwear on pain, functional and biomechanical 
outcomes on medial compartment knee osteoarthritis patients. 
 
There was no difference between flat walking shoes and flip flops compared to barefoot based 




3.5.1. Barefoot mimicking sole 
Several papers looked at barefoot mimicking shoes; all apart from one [78] used the Moleca 
shoe [77]. Trombini-Souza et al. found a reduction in the WOMAC pain subscale by 61.9% 
(p=0.003) [75]. This was replicated again by Trombini-Souza et al., with the intervention group 
showing improvement in WOMAC subscales for pain and stiffness (p=0.001). This paper also 
showed reduced analgesia intake in the intervention group [77]. Biomechanically, the Moleca 
shoe has been shown to reduce knee load during midstance by 20.2%  (p=0.003) and results in 
a 12.7% decrease (p=0.034) in the KAII [78]. In another study, it was shown to reduce the first 
peak KAM by 12%, the second peak of KAM during terminal stance by 12% compared to 
heels, with the barefoot condition having similar results to the Moleca shoe. The same study 
showed that heeled shoes increase 1st and 2nd KAM peaks compared to barefoot [76]. This 
positive effect has been reproduced in another study, showing a reduction of 21.8% in KAM 
for the intervention group [77]. Finally, Saco et al. showed that during stair descent, heeled 
shoes compared to Moleca shoes increased knee loads during early (15.5%) (P < 0.001), mid 
(9.5%) (P = 0.010) and late (9.2%) (P < 0.001) stance. Shakoor et al. looked at another 
minimalist shoe, showing an 8%  (P < 0.05) decrease in peak external KAM with a mobility 
shoe compared to a self-chosen walking shoe, and a 12%  (P < 0.05) reduction comparing the 
mobility shoe to a control [79]. The Moleca shoe showed improvement in WOMAC subscales 
for function when compared to a control shoe (p=0.001) [77]. 
 
3.5.2. Rocker soled shoe 
Two papers found no significant difference in reduction in pain with rocker soled shoes when 
compared to control shoes, either at the end the study [81], or while standing or walking (P = 
0.28) [82]. Madden et al. showed significantly reduced peak KAM between rocker soled vs 
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non-rocker shoes, but 25% of participants showed an increase. No difference was found with 
KAII; both KAM and KAM impulse were higher in both shoe conditions vs barefoot [81]. 
Knee flexion moment showed a significant reduction of 16.7% for rocker soled shoes compared 
to a control (P<0.01) [80]. Finally, the only study that reported a functional outcome was 
conducted by Nigg et al., who showed rocker soled shoes increased static balance [82]. 
3.5.3. Variable stiffness 
Erhart-Hledik et al. found that the variable stiffness types of shoes reduced the peak KAM with 
the daily activities (−5.5%, p < 0.001) [84]. WOMAC pain and total score were also 
significantly reduced. Reduction in KAM was related to improvement in pain and function 
(R2 = 0.11, p = 0.04). Finally, greater efficacy was seen in KAM reduction in the less severe 
OA group [84]. Paterson et al. (2018) found that KL grade II showed greater pain reduction in 
conventional shoes compared to unloading shoes. KL grade III+ had greater pain reduction in 
unloading shoes (P= 0.02) [83].  Neither paper looked at functional outcomes.  
 
3.6. Footwear compared to LWIs 
Jones et al. looked at several testing conditions, including different types of shoes and wedges 
[85] (See Table 7).  
 
Table 7: Studies that evaluated the effect of lateral wedge insoles versus footwear on pain and 
biomechanical outcomes on medial compartment knee osteoarthritis patients. 
 
Compared to a control shoe, typical and supported lateral wedge insoles (−5.9 and −5.6%, 
p = 0.001) and barefoot walking (−7.6% p < 0.001) reduced early stance external KAM. Similar 
improvements were seen for KAII, barefoot condition (−4.3%, p = 0.023), typical wedge 
(−7.95%, p < 0.001) and supported wedge (−5.5%, p < 0.001) compared to the control. The 
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mobility shoe showed no effect (p = 0.38). Significant reduction in latter stance was seen in 
lateral wedges compared to other conditions (p < 0.01). The mobility shoe did show a 
significant reduction in immediate knee pain and improved scores (<0.001), but did not change 
medial loading.  Lateral wedge insoles showed comparable reductions in medial knee loading 
[85]. Functional outcomes were not tested. 
4. Discussion 
4.1. Lateral insoles 
This review aimed to look into the effectiveness of foot orthoses and what orthoses features 
may contribute by looking primarily at the effect on pain, function and KAM. Firstly, looking 
at the effectiveness of LWIs, regarding pain it seems that the consensus is split as to whether 
or not LWIs have a positive effect.  Although Baker et al. found a positive mean difference in 
pain on the WOMAC pain scale, it was below the 50-point threshold for minimal perceptible 
improvement; this paper concluded that LWIs were not clinically relevant. However, the types 
of shoe worn (the importance of which will be discussed  later) and physical activity of patients 
were not controlled in this study, which may both have affected the results [54]. Bennell et al.’s 
large RCT found a below minimal clinical importance change in knee pain; however, the pain 
was only measured at baseline and 12 months follow-up [57], which could cause a type 2 error 
in findings [91]. Moreover, KL grade 1 and 4 patients were excluded from the study, which 
may have skewed the results. Two papers saw a reduction in pain medication use while pain 
scores remained the same [59, 63]. A possible reason may be that patients’ pain is reduced by 
LWIs, resulting in lower pain medication intake, causing higher activity levels, which then 
causes the same amount of pain as a baseline, however at a higher activity level [59, 63]. In a 
clinical context, this would reduce the money spent on pharmacological treatments, along with 
improving the patient’s quality of life.  Several papers used neutral insoles as their control; 
these may have the treatment efficacy of LWIs as they may have provided some discomfort 
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relief, along with a placebo effect [54, 57, 59, 60, 63]. However, LWIs’ biomechanical efficacy 
has been well documented. Several papers found that LWIs decreased unfavourable knee 
loading (either KAM or KAII) during normal walking [49, 62], and stair ascent and descent 
[55]. The mechanism for reduced KAM/KAII can be seen in Figure 1. Moreover, the 
biomechanical effectiveness remains after 1 year of use [60]. A longitudinal study 
demonstrated that a 1‐unit increase in the knee adduction moment results in a 6.46‐fold increase 
in the risk of medial disease progression [92]. Bennel et al. did show a positive association 
between tibial cartilage volume and reduced KAII [57], thus showing that LWIs may have a 
role to play in slowing down disease progression in the long term. Hsu et al. found that 
participants developed a specific gait adaptation at follow-up without the insoles. This shows 
that insoles may be used as a tool for developing a gait with reduced KAM [56]. 
All this means that while LWIs may not provide symptomatic relief, they may be clinically 
helpful in reducing unfavourable knee loads and slowing down disease progression, which in 




Research is split on the effect of insoles on pain control , with Rafiaee et al. finding a 6° insole 
to have the most significant effect on pain and function [70], and Dessery et al. finding no 
effect between their testing conditions. However, this may have been influenced by participants 
wearing insoles only for 5 trials [72], which may not have been long enough for them to feel a 
symptomatic effect. Biomechanically, the higher the wedging, the greater the KAM reduction; 
however, several participants reported pain or discomfort with the higher wedges [66, 69], with 
5° being the most comfortable.  Overall, 5° wedging seems to be a good compromise between 
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KAM reductions and discomfort levels for patients, and this is reflected in the studies, with 
most using 5° as their LWI elevation. 
 
4.1.2. Insole rigidity 
Regarding insole rigidity, studies found an overwhelmingly positive influence of either soft or 
shock absorbing insoles on patients’ pain and functional scores [64, 65]. Amongst the healthy 
population, shock absorbing/softer insoles have been shown to reduce joint loading [64]. 
However, neither papers could find an underlying biomechanical cause for this. Turpin et al. 
could not find consistent reductions in KAM; this may have been due to a small study size, 
which did not allow small reductions in joint loading to be seen. Moreover, there was a lack of 
a control group, which may have highlighted more differences [64]. Hseih et al. did not include 
biomechanical analyses in their study [65]. Overall, these findings showed either treatment 
effect, a placebo effect, or the natural history of the disease, and highlighted the disconnect 
between pain and functional scores, with joint loading. There may be scope to look into 




Only biomechanical outcomes were tested for; therefore the effect on patient clinical outcomes 
would be hypothesis-based. Full-length LWIs have a more significant effect on KAM than 
rear-foot LWIs. Hinman et al. concluded that wedging the whole lateral border of the foot 
would be a key design feature for an effective reduction in KAM [68]. This is due to a greater 
lateral shift in the centre of pressure. Moreover, rearfoot wedges only effect 30-40% of the gait 
cycle [68].  Overall full-length wedging is more effective, and this is reflected in the studies, 




4.1.4. Arch support 
A decrease in pain and increase in comfort has been associated with the use of an arch [73]. 
This may be due to an arch causing normalisation of step width [66].  Biomechanical outcomes 
showed no difference between arched and non-arched LWIs [73]. Dessery et al. found no 
difference in pain scores; this may have been due to the short time participants wore the insole 
(5 trials). Moreover, painkiller usage was not controlled, which may have blunted the pain 
response [72]. Clinically, the addition of an arch to an LWI would be done to increase comfort 
for patients, which may allow for increased adherence to treatment, With adherence being 
typically poor amongst the Knee OA population [59]. 
 
4.1.5. Customisation 
Customised insoles showed improvement in pain, function and biomechanical outcomes [66, 
67]. Skou et al. concluded that customisation may reduce adverse effects as reported by off the 
shelf insoles, whilst at the same time optimising the reduction in KAM [67]. However, the 
downfall in the current literature is that there is no paper comparing customised insoles to non-
customised insoles. Therefore, the recommendation of customising insoles for patients would 
be difficult, as it is not known if the effects are worth the extra cost. Moreover, implementation 
of a large scale customisation process in current healthcare may be difficult mainly due to the 
funding requirements, time-based barriers and material limitations.  
 
4.2. Footwear 
The literature points toward the fact that the type of footwear affects knee OA patients. 
Biomechanically, Shakoor et al. picked several common shoes and found variability in KAM 
[78]. This agrees with the NICE guidelines on giving patients advice on footwear [42].  
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However, in this study, factors influencing this difference, for example. heel height, were not 
evaluated. Moreover, participants may have changed the way they walked in different shoes as 
they were not used to them. Finally, it was not possible to take actual recommendations from 
this paper, as it would not be practical to prescribe flip flops to the elderly due to the risk of 
falls. 
 
4.2.1. Barefoot mimicking sole 
Studies looking at barefoot mimicking showed overwhelmingly positive results on pain, 
function and KAM scores. Mechanisms behind this have been postulated in several of these 
papers, with the ground reaction force being lower due to the flexibility of the shoe allowing 
for greater force application by the foot [78]. Also, increased sensory input via skin contact 
would initiate protective reflexes in the foot to minimise joint loads and impact [76]. Further 
benefits include the barefoot mimicking shoe in the studies (Moleca) being very cheap and 
sustainable. Overall, these styles of shoe may have a longer lasting effect on disease 
progression; this is hypothesis-driven, as no paper looked at specific long-term outcomes on 
knee structure/degradation. 
 
4.2.2. Rocker soled shoes 
Papers looking at rocker soled shoes found increased knee joint loads in rocker soled shoes 
compared to barefoot conditions, as well as no effect on pain [80-82], with the only positive 
outcome being increased static balance. Moreover, the rocker soled nature of the soles may not 
be safe for the elderly population. Overall, these styles of shoe do not seem to be of any real 




4.2.3. Variable stiffness 
Studies used variable stiffness shoes [83, 84], which were stiffer in the lateral aspect of the 
shoe and became softer medially. They found KAM and pain scores to be improved and found 
that these two were related. Moreover, Paterson et al. highlighted the concept of specific KL 
grade OA patients responding better to the treatment than others [83]. However, both papers 
were underpowered. Therefore, a more robust study is needed to draw a reliable conclusion. 
4.3. Footwear vs insoles 
Jones et al. is currently the only study comparing the efficacy of LWIs to different types of 
shoe in knee OA. They concluded that supported (with arch) LWIs reduced both knee load and 
pain, with the mobility shoe being the best at reducing pain scores in patients, but having no 
effect on KAM.  These findings have been backed by other literature. Pain scores were taken 
immediately after testing, introducing some potential bias in the results. Overall, further 
research in the comparison of these foot orthoses needs to be done to produce reliable 
recommendations as to which may be superior. 
5. Conclusions and future research 
This is the first review to look at what aspects of foot orthoses make them effective in knee OA 
patients. It is clear that lateral wedges create favourable knee loading conditions, which may 
affect long-term disease progression; however, their effect on pain and functional outcomes is 
still debatable. It would seem that the ideal characteristics for an LWI would be customised 
full-length, 5° elevation, shock absorbing and having arch support. Moreover, KL grade 1 and 
2 patients seem to have the most beneficial effects. However further research into the long-
term effects on disease progression is needed to make more solid claims for LWIs. Regarding 
footwear, the outlook seems more positive; barefoot mimicking shoes seem to improve 
biomechanical outcomes significantly and seem to have the greatest potential for future 
development. Further research is required to ascertain whether they have any effect on clinical 
24 
 
outcomes such as disease severity, pain and function. Finally, a valid conclusion cannot be 
drawn as to which foot orthoses are superior due to the lack of comparative studies available. 
This would be another area for future research along with determining whether there is a 
combined therapeutic effect gained by merging LWIs with barefoot mimicking shoes. Finally, 
research into which subgroups of knee OA patients respond best to foot orthoses should be 
conducted, as clearly variance is present in treatment efficacy. Overall, currently, no 
recommendations can be made to alter clinical guidelines. 
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Figure 1: The flow diagram followed using the Preferred Reporting Items for Systematic 
























Table 1: The Population Intervention Comparison Outcome (PICO) used when creating the 
search strategy 


















































Table 2: Inclusion and exclusion criteria used during the screening process of papers 
Inclusion criteria Exclusion criteria 
Types of studies- cohort studies, randomized control 
trials, randomized crossover trials, clinical 
intervention trials 
 
Studies included use/ comparison to non-foot orthoses 
i.e. knee braces, acupuncture 
 
Types of participants- adult patients (>18 years) with 
medial knee OA. Confirmed upon radiological 
investigation (KL grade 1-4) 
 
Biomechanical analyses not looking at Knee loading 
measurements 
 
Types of interventions- All types of LWI’s (with or 
without arch support, customized, varying angles of 
wedging), and all types of shoes (variable stiffness, 
varying heel heights etc.) 
 
Use of concurrent treatment i.e. altered footwear with 
insoles 
 
Types of outcome measures 
o Major- we considered KAM, WOMAC 
score, effect on pain (usually on a visual 
analogue scale (VAS)) and effect on function 
as our major outcomes 
o Minor- Knee adduction angular impulse 
(KAII), Quality of Life (QoL), pain 





medication use, along with other outcomes 









Table 3: Study characteristics of the papers included in this systematic review 
Author Study design Sample size Intervention Outcome measure Follow up 
[54] Double- blind 
crossover RCT 
90  5° LWI or a neutral 
insole . 
1°- WOMAC pain scale 
(VAS).  
2°- WOMAC disability, 
pain medication use, 
overall knee pain, 50 
feet walk time     
6 weeks. Then 
a 4 week 
washout period 





exposed to all 
conditions 
16 sulcus length shock-
absorbing insoles vs 
normal footwear 
1°- peak, early stance 
peak, late stance peak 
external KAM. KAII. 
2°- WOMAC pain 
subscale and total score, 





90 Rigid vs soft Lateral 
wedge arch 
KOOS and chronic pain 
grade questionnaire 






51 custom made insoles 
with arch support 
and a 5.08° to 8.78° 
lateral wedge 
1°-  VAS before and 
after the intervention 
after 30 minutes of 
physical activity.                     







13 full length wedges vs 
rear foot wedges 
 external KAM Immediate 
[84] blinded RCT 55 variable stiffness 
footwear vs constant 
stiffness footwear 
1°-  WOMAC total 
score and pain subscale.       






exposed to all 
conditions 
15 5 ° vs 10 ° LWI  Peak KAM Immediate 
[75] RCT 56 Flexible non heeled 
shoes (moleca) vs 
normal control 
1°-  WOMAC pain .                                
2°- Global WOMAC, 
Joint and stiffness 








exposed to all 
conditions 
31  4 different shoes and 
barefoot: 1- clogs, 2- 
stability shoes, 3- flat 
walking shoes and 4- 
flip flops 
 Peak knee loads immediate 
[71] prospective 
case control 
42 LWI vs no insole peak external KAM 
during stance phase and 
first acceleration peak 






48 Group A- Self 
chosen walking shoe 
and mobility shoe. 
Group B control 
shoe and mobility 
shoe 





exposed to all 
conditions 
30 rocker soled vs non 
rocker soled shoes 
(including barefoot) 
1°-  peak external 
KAM.            
 2°- 11 point scale for 







10 LWI (7 °  +arch 
support) 
1°-  gait analysis after 6 
weeks with and wihtout 
LWI.                






exposed to all 
conditions 
17 Masai Barefoot 
Technology (MBT) 
vs Control shoes 





exposed to all 
conditions 
45 Flexible non heeled 
shoes (moleca) vs 
modern heeled shoe 
vs barefoot 





exposed to all 
conditions 
34 Flexible non heeled 
shoes (moleca) vs 
modern heeled shoe 
vs barefoot in stair 
descent 
 Peak knee loads immediate 
[66] cross sectional 
observational 
study 
20 custom full and 
three-quarter- length 
foot orthoses with 
lateral posting of 0° 
‘neutral’, 5° rear 
foot, 10° rear foot 
and 5° forefoot/ 10° 
rear foot  
Peak knee loads immediate 
[57] RCT 200 LWI (5° )  vs Neutral 
control insole 
1°-  past week knee pain 
on an 11 point scale. 
Medial tibial cartilage 
volume.                           
2°- WOMAC score, 





[72] blinded RCT 18 no insole vs insole 
with medial arch vs 
lWI with 6° and 10° 
 Peak Knee loads and 





exposed to all 
conditions 











40 LWI (5° )  (vs no 
insole at baseline) 
1°-  immediate changes 
in static alignment and 
KAM.                               
2°- after 3 months 






156 LWI (5° )  vs Neutral 
control insole 
1°-  WOMAC score and 
Structural changes on x 
ray.       
2°- medication use 
symptomatic 
outcomes done 










20 LWI (5° )  (vs no 
insole at testing) 






56 Flexible non heeled 
shoes (moleca) vs 
normal control 
1°-   WOMAC pain 
subscale.                            
2°- other subscales of 
WOMAC. 6 minute 
walk test, KAM, 
Paracetamol intake. 









KAM and frontal plane 
motion 
12 months 
 [83] Exploratory 
analyses from 
a RCT 
164 Unloading shoes vs 
conventional 
walking shoes 







21 LWI (5° )   KAM, KAII, Centre of 
pressure displacement,  
knee ground reaction 
force lever arm 
immediate 
[62] RCT 48 LWI (5° )  vs no 
insole 
KAMs, KOOS and 
Physical Activity Scale 
for the Elderly (PASE) 





[63] double- blind 
randomised 
parallel 
treatment  trial 
118 LWI (5° )  vs Neutral 
control insole 
Edinburg functional 
scale (EKFS) was used 
to evaluate knee 
function before/after. 
End measures= severity 
of knee pain over last 2 
days. No. of NSAIDS 
used for pain relief 
within last 2 weeks and 
EKFS were assessed 
2 months 
[85] RCT 70 barefoot vs control 
shoe vs typical 
wedge vs support 
wedge vs mobility 
shoe 
EKAM, LAAI, external 
knee flexion moment, 
pain and comfort when 
walking 
immediate 
[70] RCT 36 3 vs 7mm insoles severity of knee pain, 
tibiofemoral angle, 
severity of OA and 





exposed to all 
conditions 
70 Supported vs typical 
wedges 






exposed to all 
conditions 
8 LWI vs no insole 
during eithwer stair 
ascent or descent 
KAM and KAII immediate 
[82] RCT 123 Masai Barefoot 
Technology (MBT) 
vs Control shoes 
WOMAC, BMI, OA 





















Table 4: Quality of studies included in this systematic review 
author Study design Sample 
size 
drop out rate/ 
withdrawal 
Journal Strength sampling method 
[54] Double- blind 
crossover RCT  














exposed to all 
conditions 
16 2- no reasons 
mentioned 






90 16- 13 due to 
personal time 





[67] Pre-post design 
intervention study 
51 8- 4 due to pain 
from insole, 4 did 
not give a reason 
Q2 consecutive 
[68] Pre-post design 
intervention study 
13 no drop outs Q1 consecutive 
[84] blinded RCT 55 5 drop outs- time 
commitment, 







exposed to all 
conditions 




[75] RCT 56 no drop outs Q1 block 
randomisation 
[74] Pre-post design 
with participants 
exposed to all 
conditions 




[71] prospective case 
control 




[78] Pre-post design 
intervention study 






exposed to all 
conditions 





[56] Pre-post design 
intervention study 







exposed to all 
conditions 






exposed to all 
conditions 






exposed to all 
conditions 
34 no drop outs Q1 Randomised for 
order of 
condition 
[66] cross sectional 
observational study 
20 no drop outs Q2 Randomised for 
order of 
condition 
[57] RCT 200 21-  10 due to 
refusal, 2 for knee 
replacement, 4 
lost contact, 2 
could not make 
appointments and 
1 moved overseas. 
Q1 block 
randomisation 
[72] blinded RCT 18 no drop outs Q2 Randomised for 
order of 
condition 
[49] Pre-post design 
with participants 
exposed to all 
conditions 








[59] prospective RCT 156 28- 2 to surgery, 8 
due to personal 
reasons, 12 lost to 
follow up, 6 due 
to 'other' 
Q1 Randomised 
[68] Pre-post design 
intervention study 




parallel control trial 
56 6- 1 moved away, 
2 lost interest, 1 









[60] Pre-post design 
intervention study 
38 no drop outs Q1 Randomised 
[83] Exploratory 
analyses from a 
RCT 
164 N/A Q1 randomised 
41 
 
[61] Pre-post design 
intervention study 




[62] RCT 48 5- 1 received 
extra treatment, 3 
got pain form 





[63] double- blind 
randomised parellel 
treatment  trial 
118 N/A Q2 Randomised 
[85] RCT 70 no drop outs Q1 Randomised for 
order of 
condition 
[70] RCT 36 no drop outs Q2 Randomised by 
date of birth 
[73] Pre-post design 
with participants 
exposed to all 
conditions 
70 no drop outs Q1 Randomised for 
order of 
condition 
[55] Pre-post design 
with participants 
exposed to all 
conditions 
8 no drop outs Q1 Randomised for 
order of 
condition 






























Table 5: List of studies that evaluated the effect of foot orthoses on pain, functional and 
biomechanical outcomes on medial compartment knee osteoarthritis patients 
 
[54] 90 5° LWI or a neutral 
insole 
1°-  WOMAC pain 




overall knee pain, 50 
feet walk time     
13.8‐point effect (95% CI −3.9, 31.4) 
[P=0.13] on pain. No change in pain 
medication. Similar small effects seen in  2° 
outcomes.  
[56] 10 LWI (7 °  +arch 
support) 
1°-  gait analysis after 
6 weeks with and 
without LWI.                
2°-  WOMAC score 
WOMAC scores decreased after 6 weeks. 
KAM with insoles was significantly reduced 
at baseline (p < 0.05). specific gait adaptation 
with reduced knee loading was revealed when 
walking without LW insoles 
[57] 200 LWI (5° )  vs 
Neutral control 
insole 
1°-  past week knee 
pain on an 11 point 
scale. Medial tibial 
cartilage volume.                           
2°-  WOMAC score, 
progression of medial 
cartilage defects. 
No significant difference for the 1° outcome 
or the s 2° outcomes. 




KAM, KAII, centre 
of pressure 
LWI reduced peak KAM (-5.8%) and angular 
impulse (-6.3%) (P<0.001). Reductions in 
peak KAM correlated with more lateral 
Centre of pressure (r=0.25, P<0.05), less 
Varus misalignment (r values 0.25-0.38, 
P<0.05), reduced Knee Ground Reaction 
Force (r=0.69, P<0.01), more vertical frontal 
plane ground reaction force vector  (r=0.67, 
P<0.001. Only knee-ground reaction force 
lever arm was significantly predictive in 
regression analyses  P<0.001 
[49] 40 LWI (5° )  (vs no 
insole at baseline) 
1°-  immediate 
changes in static 
alignment and KAM.                               
2°- after 3 months 
changes in pain and 
functioning via 
WOMAC 
Reduction in Kam for insoles -0.22% and 
reduction in walking pain -24%. No mean 
effect on static alignment. Mean 
improvements in WOMAC pain and function 
was observed at 3 months (P = 0.004). 
Regression analyses demonstrated that 
disease severity, baseline functioning and 
magnitude of immediate change in walking 
pain and first peak KAM was predictive of 
clinical outcome at 3 months. (24% of the 
variance in WOMAC pain score) 
[59] 156 LWI (5° )  vs 
Neutral control 
insole 
1°-  WOMAC score 
and Structural 
changes on x ray.      
2°- medication use 
No statistical significant difference between 
groups for improvement in WOMAC scores. 
Number of days NSAIDs taken decreased 
with LWI group. Joint space narrowing had 








KAM and frontal 
plane motion 
Increased KAM and frontal plane motion 
over 1 year in control group. Mechanical 
effectiveness did not decrease over time. 
[61] 21 LWI (5° )   KAM, KAII, Centre 
of pressure 
displacement,  knee 
ground reaction force 
lever arm 
LWI decreased 1st KAM significantly (10%), 
however no difference in the abnormal foot 
group. Decreased rear foot eversion strongly 
correlated with reduction in 1st KAM in 
normal foot. No significant difference based 
on K/L grade.  Centre of pressure was offset 
and ankle exhibited significant increased 
eversion excursion with LWIS. 
[62] 48 LWI (5° )  vs no 
insole 
KAMs, Knee Injury 
and Osteoarthritis 
Outcome Score 
(KOOS) and Physical 
Activity Scale for the 
Elderly (PASE) 
scores were measured 
at baseline 
No statistical difference in KOOS pain as 
found in lateral wedge group (p=0.173). No 
association in KAM reduction and change in 
KOOS pain 




scale (EKFS) was 
used to evaluate knee 
function before/after. 
End measures= 
severity of knee pain 
over last 2 days. No. 
of NSAIDS used for 
pain relief within last 
2 weeks and EKFS 
were assessed 
Severity of pain  (VAS) decreased in both 
groups after intervention (difference being 
29.3%, AND 6.25%) (P < 0.001 for both). 
Significant improvement in EKFS for LWI( P 
< 0.001). No. of nsaids used during last 2 
weeks significantly reduced in wedge group 
(P = 0.001. 
[55] 8 LWI vs no insole 
during eithwer stair 
ascent or descent 
KAM and KAII During stair ascent and descent LWI 
significantly reduced 1st peak EXKAM in 
early stance, trough in mid stance, 2nd peak 
in late stance and KAAI compared to control  
(All P<0.05)  
[64] 16 sulcus length 
shock-absorbing 
insoles vs normal 
footwear 
1°-  peak, early 
stance peak, late 
stance peak external 
KAM. KAII. 
 2°- WOMAC pain 
subscale and total 
score, timed stair 
climb 
Significant reduction in the late stance peak 
KAM with shock-absorbing insoles (P=0.03) 
during follow-up compared with the baseline 
test session. Significant improvements seen in 
all measures of pain and function (P<0.05) 
[65] 90 Rigid vs soft 
Lateral wedge arch 
Knee Injury and 
Osteoarthritis 
Outcome Score 
(KOOS) and chronic 
pain grade 
questionnaire 
significant time × group effect improvements 
in pain (P = 0.008 for the KOOS), stair ascent 
time (P = 0.003), daily living function (P = 
0.003 for the KOOS), sports and recreation 
function (P = 0.012 for the KOOS), and 
quality of life (P = 0.021 for the KOOS) in 
the soft LWAS insole group 
44 
 
[67] 51 custom made 
insoles with arch 
support and a 5.08° 
to 8.78° lateral 
wedge 
1°-   VAS before and 
after the intervention 
after 30 minutes of 
physical activity.                     
2°-  Oxford Knee 
Score and EQ-5D 
VAS after 30 min of physical activity was 
significantly reduced after the intervention ( 
P= .001). Similar changes seen for  
2°outcomes. 
[66] 20 custom full and 
three-quarter- 
length foot orthoses 
with lateral posting 
of 0° ‘neutral’, 5° 
rear foot, 10° rear 
foot and 5° 
forefoot/ 10° rear 
foot  
Peak knee loads showed full length orthoses provided greater 
reduction in first and second (5° forefoot/10° 
rear foot wedging ) KAM and KAM impulse 
compared to ¾ insoles (p = 0.038) (p = 
0.018). dose effect found for wedge height 
and reduction on first  A, second (p = 0.028)  
and KAM impulse (p = 0.036) . There was a 
significant interaction effect of length and 
wedging condition for second peak knee 
adduction moment  (p = 0.002). There was 
variability in the response to LWI 
[68] 13 full length wedges 
vs rear foot wedges 
 external KAM Full length wedge reduced KAM by 12-14% 
(P < 0.05). Rear foot had no effect (P < 0.05) 
[69] 15 5 ° vs 10 ° LWI  Peak KAM  Compared with no insole, the 5° wedge 
reduced the peak KAM by about 6% and the 
10° wedge reduced the peaks by about 8%. 
Reduction in KAM compared to neutral 
insoles. 10° insole was associated with 
degrees of discomfort. 
[70] 36 3 vs 7mm insoles severity of knee pain, 
tibiofemoral angle, 
severity of OA and 
quality of life 
Both wedges improved QOL and decreased 
knee joint pain, however greater effect with 
7mm.  
[71] 42 LWI vs no insole  peak external KAM 
during stance phase 
and first acceleration 
peak after heel strike. 
LWI significantly reduced the peak external 
KAM in KL grades I (5.1% P=<0.043)  and II 
(6.6%, P=<0.010) grade 
III (3.3%, p<0.058), and IV (5.0%, P<0.086) . 
The first acceleration peak value after heel 
strike in these patients was relatively high 
compared with the control. Application of 
LWI significantly reduced the first 
acceleration peak in KL grades I (p<0.024) 
and II (P<0.043) knee OA patients but not III 
and IV patients. 
[72] 18 no insole vs insole 
with medial arch vs 
lWI with 6° and 10° 
 Peak Knee loads and 
pain and comfort 
scores 
6% decrease in 2nd peak KAM in LWI 
conditions compared to others (p<0.001). 7% 
significant increase in in KAM during 
loading response in neutral insole with medial 




[73] 70 Supported vs 
typical wedges 
external KAM and 
Knee pain 
significant decrease in pain seen in supported 
wedges ( p < 0.001) . EKAM was reduced in 
both LWIs versus control shoe (−5.21% and 
−6.29% for typical and supported wedges). 
54% where biomechanical responders, but 
these people did not have more knee pain 


















































Table 6: Studies that evaluated the effect of footwear on pain, functional and biomechanical 
outcomes on medial compartment knee osteoarthritis patients. 
author Sample 
size 
Intervention outcome measure results 
[74] 31  4 different shoes 
and barefoot: 1- 
clogs, 2- stability 
shoes, 3- flat 
walking shoes and 
4- flip flops 
 Peak knee loads clogs and stability shoes, resulted in a 
significantly higher peak knee adduction 
moment (p<0.05) compared with that of 
flat walking shoes , flip-flops and barefoot 
walking. No difference in flat walking 
shoes and flip flops compared to barefoot. 




1°-  WOMAC pain .                                
2°- Global 
WOMAC, Joint and 
stiffness WOMAC. 
Six minute walk test. 
The 1° outcome (WOMAC subscale pain) 
decreased 61.9%. increase in WOMAC 
function subscale 
(44.9%), and WOMAC total score (49.3%). 
a 20.2% decrease (p=0.003) in the knee 
load at 
midstance, and a 12.7% decrease (p=0.034) 
in the KAM 
angular impulse. Increase in KAM first 
peak for Control group. 
[78] 48 Group A- Self 
chosen walking 
shoe and mobility 
shoe. Group B 
control shoe and 
mobility shoe 
peak external KAM  Group A showed an 8% ( P < 0.05) 
decrease in peak external KAM with 
mobility shoe compared to self chosen 
walking shoe. Group B showed a 12%  (P < 
0.05) reduction comparing mobility shoe to 
control. 




shoe vs barefoot 
Peak knee loads Moleca reduced the first peak KAM by 
12% and 10.8% for the OAG and CG,  
second peak of KAM during terminal 
stance by 12% for the OAG and 15.7% for 
the CG compared to heels. Barefoot had 
similar results as the Moleca shoe. Heeled 
shoes increase first and second KAM peaks 
compared to barefoot. For OAG the Moleca 
resulted in a 12% decrease in the first peak 
of KAM during midstance when compared 
to the barefoot. Overall Moleca shoes 
showed a similar KAM to that of barefoot 
walking, while heeled shoes showed an 
increase 




shoe vs barefoot in 
stair descent 
 Peak knee loads The OA group had similar knee load during 
early, mid and late stance with the Moleca 
compared to the barefoot condition. Heeled 
shoes increase knee loads during early vs 
Moleca (15.5%) (P < 0.001) , in mid vs 
Moleca (9.5%) (P = 0.010) and late vs 
Moleca ( 9.2%) (P < 0.001).  




1°- WOMAC pain 
subscale.                            
2°- other subscales 
of WOMAC. 6 
minute walk test, 
KAM, Paracetamol 
intake. 
intervention group showed improvement in 
WOMAC subscales for pain, function, 
stiffness (p=0.001). Reduction of 21.8% in 
KAM for intervention group. Analgesia 
was also decreased 
47 
 
[81] 30 rocker soled vs non 
rocker soled shoes 
(including 
barefoot) 
1°-  peak external 
KAM.           
 2°- 11 point scale 
for knee pain whilst 
walking  
Peak KAM was significantly reduced 
between rocker soled vs non rocker shoes. 
No difference in KAM impulses. Both 
KAM and KAM impulse was higher in 
both shoe conditions vs barefoot. No 
difference in knee pain between conditions.  
[80] 17 Masai Barefoot 
Technology 
(MBT) vs Control 
shoes 
Peak knee loads knee flexion moment showed a significant 
reduction of 16.7% for MBT shoes 
compared to control P<0.01. No change in 
KAM 
[82] 123 Masai Barefoot 
Technology 
(MBT) vs Control 
shoes 
WOMAC, BMI, OA 
index, Active range 
of motion 
MBT shoe showed increased static balance. 
No difference between groups in the 
reduction in pain, standing or walking (P = 
0.28) 




1°-  WOMAC total 
score and pain 
subscale.       
 2°- peak KAM 
variable stiffness shoe reduced within day 
peak KAM (−5.5%, p < 0.001). WOMAC 
pain and total score was significantly 
reduced. Reduction in KAM was related to 
improvement in pain and function  
(R2 = 0.11, p = 0.04).  Greater efficacy in 
KAM reduction in less severe OA group 
 [83] 164 Unloading shoes 
vs conventional 
walking shoes 
 6 month change in 
knee pain  
KL=2 experiences greater pain reductions 
in conventional shoe compared to 
unloading. KL=3+ had greater pain 
reduction in unloading shoes, this maybe 





















Table 7: Studies that evaluated the effect of lateral wedge insoles versus footwear on pain and 







[73] 70 barefoot vs 












Compared to control shoe, typical and supported 
lateral wedge insoles (−5.9 and −5.6%, p = 0.001 ) 
and barefoot walking (−7.6% p < 0.001) reduced 
early stance external KAM . Similar improvements 
were seen for KAII, barefoot condition 
(−4.3%, p = 0.023), typical wedge 
(−7.95%, p < 0.001), supported wedge 
(−5.5%, p < 0.001) compared to control. Mobility 
shoe showed no effect (p = 0.38). Significant 
reduction in latter stance EKAM seen in lateral 
wedge compared to other conditions p < 0.01. 
Mobility shoe did show significant reduction in 
immediate knee pain and improves scores (<0.001), 
but did not change medial loading.  Lateral wedge 
insoles shoes comparable reductions in medial knee 
loading 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
